ClinicalTrials.gov
ClinicalTrials.gov Menu

Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00323726
Recruitment Status : Withdrawn (The study was limited to IRB Exempt chart review; not an applicable trial.)
First Posted : May 9, 2006
Last Update Posted : June 18, 2015
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance

Brief Summary:
Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study

Condition or disease
Ovarian Cancer

Detailed Description:
This is a chart review.

Study Type : Observational
Actual Enrollment : 0 participants
Time Perspective: Retrospective
Official Title: Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study
Study Start Date : December 2005
Actual Primary Completion Date : December 2006
Actual Study Completion Date : December 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with ovarian germ cell tumors
Criteria

Inclusion Criteria:

  • Patients with Ovarian Germ Cell Tumors in the last 27 years.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00323726


Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Harriet Smith, MD University of New Mexico

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00323726     History of Changes
Other Study ID Numbers: HRRC 02-579
First Posted: May 9, 2006    Key Record Dates
Last Update Posted: June 18, 2015
Last Verified: June 2015

Additional relevant MeSH terms:
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms